• SENSEX 80,710.76
    -7.25 (--0.01%)
  • BANKNIFTY 54,114.55
    39.10 (+0.07%)
Back

Corporate News

Relonchem receives UK MHRA approval for its products
18-Aug-2025, 12:59

Marksans Pharma  announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for the below-mentioned products from UK MHRA:

  1. Metformin Hydrochloride Relonchem 500 mg Prolonged Release Tablets
  2. Metformin Hydrochloride Relonchem 750 mg Prolonged Release Tablets
  3. Metformin Hydrochloride Relonchem 1000 mg Prolonged Release Tablets

Powered by Capital Market - Live News